M. Arnold

发表

Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design

S. Connolly, S. Hohnloser, J. Rouleau, 2009, Current opinion in cardiology.

Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).

J. Healey, D. Exner, G. Wells, 2014, Canadian Journal of Cardiology.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

John L Sapp, Graham Nichol, George A Wells, 2010, The New England journal of medicine.

Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.

R. Goeree, L. Mitchell, H. Ross, 2005, The Canadian journal of cardiology.

Registry of Myocarditis and Heart Failure

Peter P. Liu, M. Arnold, M. Nian, 2003 .

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

G. Lamas, M. Pfeffer, J. Rouleau, 1994, Circulation.

Apical wall stress by finite element analysis predicts subsequent left ventricular remodeling in the healing and early afterload reducing trial

Richard T. Lee, S. Solomon, M. Pfeffer, 1998 .

Tumor Necrosis Factor- Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State

R. Khokha, L. Kirshenbaum, T. Parker, 2007 .

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Alexander G Logan, Michael D Hill, Pierre Larochelle, 2009, The Canadian journal of cardiology.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2007, The Canadian journal of cardiology.

Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease

B. Davis, M. Pfeffer, F. Sacks, 2008, Circulation.

The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.

S. Yusuf, R. McKelvie, J. Rouleau, 2001, The Canadian journal of cardiology.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2008, The Canadian journal of cardiology.

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure

Akshay S. Desai, S. Solomon, J. McMurray, 2014, European heart journal.

Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study.

S. Keteyian, G. Ewald, M. Gheorghiade, 2011, American heart journal.

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

G. Lamas, M. Pfeffer, J. Rouleau, 1997, Circulation.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Lawrence A Leiter, E. Schiffrin, F. McAlister, 2006, The Canadian journal of cardiology.

Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes.

T. Peng, Q. Feng, M. Arnold, 2009, Cardiovascular research.

Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.

S. Solomon, M. Pfeffer, R. Glynn, 2001, American heart journal.

Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial

James A. White, B. Chow, J. Tardif, 2013, Trials.

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

D. J. Veldhuisen, N. Stockbridge, M. Vaduganathan, 2014, Heart Failure Reviews.

Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.

Francis G Spinale, Malcolm Arnold, Catherine Demers, 2006, Journal of cardiac failure.

Routine versus selective cardiac magnetic resonance in non-ischemic heart failure – OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B)

James A. White, B. Chow, G. Wright, 2013, Trials.

Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis.

S. Solomon, M. Pfeffer, J. Rouleau, 2001, American heart journal.

Changes in the Minnesota Living With Heart Failure Questionnaire Score and Clinical Outcomes in a Large Contemporary Population of Ambulatory Heart Failure Patients in the Canadian Heart Failure Network

G. Marchiori, A. Kaan, A. Ignaszewski, 2012 .

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Alexander G Logan, Pierre Larochelle, Malcolm Arnold, 2005, The Canadian journal of cardiology.

Prognostic use of echocardiography 1 year after a myocardial infarction.

G. Lamas, S. Solomon, M. Pfeffer, 2005, American heart journal.

Novel risk factors for heart failure when the whole may be greater than the sum of its parts.

M. Arnold, ichard E. Gilbert, 2009, Journal of the American College of Cardiology.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

J. Healey, S. Connolly, S. Hohnloser, 2010, The New England journal of medicine.